"It's flat wrong." Lilly's major competitors Novo Nordisk and Sanofi have offered programs in the past to curb insulin costs. Novo Nordisk offered a cash card program and some price cuts in 2020 ...

Drug giant Eli Lilly has announced a $35 (£30) cap on the monthly costs patients face for insulin in the US, responding to outcry over the soaring cost of the diabetes medication. More than eight ...